Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Clinical Kidney Journal|November 2, 2023
Epidemiology and predictors of hyponatremia in a contemporary cohort of patients with malignancy: a retrospective cohort studyMiho Murashima, Kaori Ambe, Yuka Aoki, et al.
The Journal of Reproduction and Development|November 13, 2010
Relationships between the first ovulation postpartum and polymorphism in genes relating to function of immunity, metabolism and reproduction in high-producing dairy cowsKoumei Shirasuna, Chiho Kawashima, Chiaki Murayama, et al.
Oncotargets and Therapy|October 23, 2015
Molecular diagnostics of a single drug-resistant multiple myeloma case using targeted next-generation sequencingHiroshi Ikeda, Kazuya Ishiguro, Tetsuyuki Igarashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 19, 2015
[A case of primary mediastinal (Thymic) B-cell lymphoma successfully treated with the DA-EPOCH-R Regimen]Yukiko Higashide, Toshiaki Hayashi, Daisuke Hirayama, et al.
British Journal of Pharmacology|August 29, 2012
AKAP-dependent sensitization of Ca(v) 3.2 channels via the EP(4) receptor/cAMP pathway mediates PGE(2) -induced mechanical hyperalgesiaFumiko Sekiguchi, Yuka Aoki, Maiko Nakagawa, et al.
Biomedical Research (Tokyo, Japan)|August 11, 2017
DEC1 promotes hypoxia-induced epithelial-mesenchymal transition (EMT) in human hepatocellular carcinoma cellsKeishu Murakami, Yunyan Wu, Tadaatsu Imaizumi, et al.
Clinical and Translational Science|January 6, 2025
Prediction of Cisplatin-Induced Acute Kidney Injury Using an Interpretable Machine Learning Model and Electronic Medical Record InformationKaori Ambe, Yuka Aoki, Miho Murashima, et al.
Metabolites|August 23, 2020
L-Ascorbate Biosynthesis Involves Carbon Skeleton Rearrangement in the Nematode <i>Caenorhabditis elegans</i>Yukinori Yabuta, Ryuta Nagata, Yuka Aoki, et al.
The Journal of Organic Chemistry|October 29, 2013
Michael addition-aromatization reaction of dienylimines bearing a leaving group and its application to the preparation of thiol-selective labeling reagents capable of forming strong carbon-sulfur bondsTetsuya Miyoshi, Yuka Aoki, Yumina Uno, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 28, 2011
Irinotecan as the key chemotherapeutic agent in second-line treatment of metastatic gastric cancer after failure of first-line S-1 or S-1/CDDP therapyAkira Goto, Yasutaka Sukawa, Hisayoshi Igarashi, et al.
Pageof 4